20 Feb 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences obtient 1,7 million d’euros de financement « Avance Innovation » auprès de Bpifrance
|
20103010 Biotechnology |
- |
17 Feb 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL : bilan semestriel du contrat de liquidité 2ème semestre 2022
|
20103010 Biotechnology |
- |
02 Feb 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences collaborates with the CEA
|
20103010 Biotechnology |
- |
02 Feb 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences collabore avec le CEA
|
20103010 Biotechnology |
- |
31 Jan 2023
07:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: Very successful capital increase for NFL Biosciences with over €3 million raised
|
20103010 Biotechnology |
- |
31 Jan 2023
07:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : Très fort succès de l’augmentation de capital de NFL Biosciences avec plus de 3 millions d’euros levés
|
20103010 Biotechnology |
- |
30 Jan 2023
18:26 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences launches a round of fundraising for approximately 2.5 million euros
|
20103010 Biotechnology |
- |
30 Jan 2023
17:58 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences lance une levée de fonds d’environ 2,5 millions d’euros
|
20103010 Biotechnology |
- |
20 Jan 2023
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences : avancement de l’étude CESTO II en ligne avec le calendrier
|
20103010 Biotechnology |
- |
20 Jan 2023
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences: CESTO II trial progressing on schedule
|
20103010 Biotechnology |
- |
17 Jan 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences : Agenda de communication financière du 1er semestre 2023
|
20103010 Biotechnology |
- |
17 Jan 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences: Financial calendar for the first half of 2023
|
20103010 Biotechnology |
- |
11 Jan 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences reçoit une subvention conjointe de l’Etat Français et de la Région Occitanie pour son étude clinique PRECESTO
|
20103010 Biotechnology |
- |
11 Jan 2023
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences receives a joint grant from the French Government and the Occitanie Region for its PRECESTO clinical trial
|
20103010 Biotechnology |
- |
04 Jan 2023
18:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : nombre d'actions et droits de vote au 31.12.2022
|
20103010 Biotechnology |
- |
09 Dec 2022
11:43 CET |
NFL BIOSCIENCES S.A. |
NFL : nombre d'actions et droits de vote au 30.11.2022
|
20103010 Biotechnology |
- |
08 Nov 2022
18:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: CLINICAL TRIAL APPROVED TO DEMONSTRATE THE COMPLEMENTARITY OF NFL-101 WITH OTHER SMOKING CESSATION TREATMENTS
|
20103010 Biotechnology |
- |
08 Nov 2022
18:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : AUTORISATION D’ESSAI CLINIQUE POUR DÉMONTRER LA COMPLÉMENTARITÉ DE NFL-101 AVEC LES AUTRES TRAITEMENTS DE SEVRAGE TABAGIQUE
|
20103010 Biotechnology |
- |
02 Nov 2022
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: NEW PATENT APPLICATION ASSOCIATING NFL-101 WITH OTHER SMOKING CESSATION TREATMENTS
|
20103010 Biotechnology |
- |
02 Nov 2022
08:00 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : NOUVELLE DEMANDE DE BREVET ASSOCIANT NFL-101 AUX AUTRES TRAITEMENTS DE SEVRAGE TABAGIQUE
|
20103010 Biotechnology |
- |
25 Oct 2022
07:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences: 2022 first-half business and earnings
|
20103010 Biotechnology |
- |
25 Oct 2022
07:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences : Activités & Résultats du 1er semestre 2022
|
20103010 Biotechnology |
- |
05 Oct 2022
18:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES PARTNERS WITH THEMIS MEDICARE FOR THE DEVELOPMENT OF NFL-101 IN INDIA
|
20103010 Biotechnology |
- |
05 Oct 2022
18:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES CONCLUT UN PARTENARIAT AVEC THEMIS MEDICARE POUR LE DÉVELOPPEMENT DE NFL-101 EN INDE
|
20103010 Biotechnology |
- |
26 Jul 2022
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S1 2022
|
20103010 Biotechnology |
- |
26 Jul 2022
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES HALF-YEAR REVIEW OF THE LIQUIDITY AGREEMENT FOR H1 2022
|
20103010 Biotechnology |
- |
11 Jul 2022
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES confirme le renouvellement de son éligibilité au PEA-PME
|
20103010 Biotechnology |
- |
24 Jun 2022
18:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE
|
20103010 Biotechnology |
- |
24 Jun 2022
18:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : PARTICIPATION À LA H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE
|
20103010 Biotechnology |
- |
25 May 2022
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES, which is committed to the fight against smoking, fully supports World No Tobacco Day on May 31
|
20103010 Biotechnology |
- |
25 May 2022
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES, engagé dans la lutte contre le tabagisme, souscrit pleinement à la Journée Mondiale Sans Tabac du 31 mai
|
20103010 Biotechnology |
- |
11 May 2022
18:15 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea
|
20103010 Biotechnology |
- |
11 May 2022
18:15 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Corée du Sud
|
20103010 Biotechnology |
- |
29 Apr 2022
17:45 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences : Mise à disposition du Rapport Annuel au 31/12/2021
|
20103010 Biotechnology |
- |
11 Apr 2022
18:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: Notice of allowance of its patent in China
|
20103010 Biotechnology |
- |
11 Apr 2022
18:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Chine
|
20103010 Biotechnology |
- |
28 Mar 2022
07:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences: 2021 full-year business and earnings update
|
20103010 Biotechnology |
- |
28 Mar 2022
07:00 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences : Activités & Résultats annuels 2021
|
20103010 Biotechnology |
- |
02 Feb 2022
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: co-development agreement for a drug candidate to reduce alcohol consumption
|
20103010 Biotechnology |
- |
02 Feb 2022
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : accord de co-développement d’un candidat médicament pour réduire la consommation d’alcool
|
20103010 Biotechnology |
- |
12 Jan 2022
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE S2 2021
|
20103010 Biotechnology |
- |
12 Jan 2022
17:45 CET |
NFL BIOSCIENCES S.A. |
Nfl Biosciences: Half-Year Review of the Liquidity Agreement for h2 2021
|
20103010 Biotechnology |
- |
14 Dec 2021
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences : lancement de l’étude clinique de Phase II/III pour le sevrage tabagique
|
20103010 Biotechnology |
- |
14 Dec 2021
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL Biosciences: Phase II/III clinical trial launched for smoking cessation
|
20103010 Biotechnology |
- |
17 Nov 2021
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : accord de production de ses principes actifs avec Diverchim
|
20103010 Biotechnology |
- |
17 Nov 2021
17:45 CET |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: agreement signed with Diverchim to manufacture its active ingredients
|
20103010 Biotechnology |
- |
04 Oct 2021
08:15 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences : Mise à disposition du Rapport Financier Semestriel au 30 juin 2021
|
20103010 Biotechnology |
- |
04 Oct 2021
08:15 CEST |
NFL BIOSCIENCES S.A. |
NFL Biosciences: Availability of the Half Year Financial Report as of June 30, 2021
|
20103010 Biotechnology |
- |
04 Oct 2021
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES: 2021 half-year financial and business report
|
20103010 Biotechnology |
- |
04 Oct 2021
08:00 CEST |
NFL BIOSCIENCES S.A. |
NFL BIOSCIENCES : Activités et résultats du 1er semestre 2021
|
20103010 Biotechnology |
- |